PDS Biotechnology (STU:EU6) Short-Term Debt : €11.26 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is PDS Biotechnology Short-Term Debt?

PDS Biotechnology's Short-Term Debt for the quarter that ended in Sep. 2024 was €11.26 Mil.

PDS Biotechnology's quarterly Short-Term Debt increased from Mar. 2024 (€6.71 Mil) to Jun. 2024 (€9.68 Mil) and increased from Jun. 2024 (€9.68 Mil) to Sep. 2024 (€11.26 Mil).

PDS Biotechnology's annual Short-Term Debt stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€3.82 Mil).

PDS Biotechnology Short-Term Debt Historical Data

The historical data trend for PDS Biotechnology's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PDS Biotechnology Short-Term Debt Chart

PDS Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

3.82

PDS Biotechnology Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															-	3.82	6.71	9.68	11.26

PDS Biotechnology Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PDS Biotechnology Short-Term Debt Related Terms

Thank you for viewing the detailed overview of PDS Biotechnology's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PDS Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PDS Biotechnology Corp (STU:EU6) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

PDSB:USA

Address

303A College Road, East Princeton, NJ, USA, 08540

Website

https://www.pdsbiotech.com

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

PDS Biotechnology Headlines

No Headlines